Free Trial

Oric Pharmaceuticals (ORIC) SEC Filings & 10K Form

Oric Pharmaceuticals logo
$10.65 -0.15 (-1.39%)
As of 07/7/2025 04:00 PM Eastern

Recent Oric Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/24/2025
5:33 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:05 PM
Oric Pharmaceuticals (Filer)
Form 424B3
06/23/2025
7:05 PM
Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2025
11:15 PM
Oric Pharmaceuticals (Filer)
Form EFFECT
06/13/2025
6:38 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
5:37 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:18 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:16 PM
Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
11:22 AM
Oric Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/05/2025
4:17 PM
Oric Pharmaceuticals (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13D
06/04/2025
3:32 PM
Oric Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
05/30/2025
3:35 PM
Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G
05/28/2025
3:42 PM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:47 PM
Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
8:42 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Oric Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:10 PM
Oric Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:15 PM
Oric Pharmaceuticals (Filer)
Form ARS
03/20/2025
3:25 PM
Oric Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
4:27 PM
Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:30 AM
FMR LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:43 PM
Dier Mardi (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:44 PM
Heyman Richard A. (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:45 PM
Hoerter Steven L. (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:46 PM
Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:47 PM
Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:42 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:21 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:22 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:23 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:31 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:34 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:29 PM
Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:54 PM
EcoR1 Capital, LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
4:47 PM
Nextech Crossover I GP S.a r.l. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
8:42 AM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G
08/12/2024
3:20 PM
Oric Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Elon’s NEXT Big IPO? (Ad)

Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.

One that experts predict could be worth over $3.2 TRILLION globally by 2030.
08/12/2024
3:10 PM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORIC) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners